This HTML5 document contains 37 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/drugbank/drug/DB02197/identifier/pdb/
n7http://linked.opendata.cz/resource/drugbank/drug/DB02197/identifier/bindingdb/
n11http://linked.opendata.cz/resource/drugbank/drug/DB02197/identifier/pubchem-compound/
n15http://linked.opendata.cz/resource/drugbank/drug/DB02197/identifier/pubchem-substance/
n14http://linked.opendata.cz/resource/drugbank/drug/DB02197/identifier/drugbank/
n9http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n13http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n12http://linked.opendata.cz/resource/drugbank/drug/DB02197/identifier/chemspider/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB02197
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n9:DB02197 n13:DB02197
dcterms:title
4-[(4-Imidazo[1,2-a]Pyridin-3-Ylpyrimidin-2-Yl)Amino]Benzenesulfonamide
adms:identifier
n7:7657 n10:HDT n11:5288527 n12:4450680 n14:DB02197 n15:46504935
n3:IUPAC-Name
n4:271B4701-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4707-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4706-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4703-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4704-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4705-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B46FF-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B46FD-363D-11E5-9242-09173F13E4C5 n4:271B4700-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B46FE-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B470D-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B470E-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4708-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4709-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B470B-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B470A-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B470C-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4713-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4715-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4716-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4712-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4711-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4714-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4702-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B470F-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4710-363D-11E5-9242-09173F13E4C5